User profiles for Mahmuda Yeasmin

Mahmuda Yeasmin

- Verified email at ld.dghs.gov.bd - Cited by 199

Mahmuda Yeasmin

- Verified email at monash.edu - Cited by 33

SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts

…, T Nafisa, MMA Molla, M Yeasmin… - Scientific reports, 2021 - nature.com
The microbiota of the nasopharyngeal tract (NT) play a role in host immunity against respiratory
infectious diseases. However, scant information is available on interactions of SARS-CoV…

[HTML][HTML] Antibiotic prescribing patterns at COVID-19 dedicated wards in Bangladesh: Findings from a single center study

MMA Molla, M Yeasmin, MK Islam, MM Sharif… - Infection prevention in …, 2021 - Elsevier
Background As evidence is mounting regarding irrational and often unnecessary use of
antibiotics during the COVID-19 pandemic a cross-sectional Point Prevalence Survey (PPS) (in …

Safety and immunogenicity of Zika virus vaccine: A systematic review of clinical trials

M Yeasmin, MMA Molla, HMAA Masud… - Reviews in Medical …, 2023 - Wiley Online Library
Several phase‐1 clinical trials have been performed to evaluate the safety and efficacy of
candidate anti‐Zika vaccines. In this systematic review, we systematically evaluated the safety …

Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

Y Jiang, M Yeasmin, AB Gondin… - British Journal of …, 2023 - Wiley Online Library
Background and Purpose Affinity‐based, selective orthosteric ligands for the muscarinic
acetylcholine receptors (mAChRs) are difficult to develop due to high sequence homology …

Spike protein mutations and structural insights of pangolin lineage B. 1.1. 25 with implications for viral pathogenicity and ACE2 binding affinity

…, MS Uzzaman, T Nafisa, MA Molla, M Yeasmin… - Scientific Reports, 2023 - nature.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
COVID -19, is constantly evolving, requiring continuous genomic surveillance. In this study, …

Clinical presentation of COVID-19 and antibody responses in Bangladeshi patients infected with the Delta or Omicron variants of SARS-CoV-2

AK Ghosh, O Landt, M Yeasmin, M Sharif, RH Ratul… - Vaccines, 2022 - mdpi.com
The clinical presentation of COVID-19 and the specific antibody responses associated with
SARS-CoV-2 variants have not been investigated during the emergence of Omicron variants …

Decreasing transmission and initiation of countrywide vaccination: Key challenges for future management of COVID‐19 pandemic in Bangladesh

MMA Molla, JA Disha, M Yeasmin… - … Journal of Health …, 2021 - Wiley Online Library
With a fragile healthcare system, Bangladesh, much like other countries in South East Asia,
struggled during the early days of COVID‐19 pandemic. In following months several …

Molecular and serological characterization of the SARS-CoV-2 delta variant in Bangladesh in 2021

AK Ghosh, M Kaiser, MMA Molla, T Nafisa, M Yeasmin… - Viruses, 2021 - mdpi.com
Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other
variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade …

Coding-complete genome sequences of three SARS-CoV-2 strains from Bangladesh

…, T Nafisa, MMA Molla, M Yeasmin… - Microbiology …, 2020 - Am Soc Microbiol
We report the sequencing of three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
genomes from Bangladesh. We have identified a unique mutation (NSP2_V480I) in …

Identification of a Novel Allosteric Site at the M5 Muscarinic Acetylcholine Receptor

…, G Thompson, M Yeasmin… - ACS Chemical …, 2021 - ACS Publications
The M 5 muscarinic acetylcholine receptor (mAChR) has emerged as an exciting therapeutic
target for the treatment of addiction and behavioral disorders. This has been in part due to …